Optima Tyler’s most useful pricing detail is also the easiest to misread: its advertised amounts cover 10-week programs, not calendar months. The Texas business lists compounded semaglutide at $249 and compounded tirzepatide at $349, including consultation, medication, supplies and shipping. That gives prospective patients a concrete starting point without requiring a monthly-price conversion. It does not establish the cost of continuing treatment, the quantity dispensed in a shipment or a mandatory 10-week payment commitment. Those are separate questions that the advertised program length alone cannot answer.
This review examines the provider’s pages and terms consulted October 19, 2026, focusing on what a self-paying adult can establish before purchasing. Optima describes locally owned care, statewide Texas telehealth and continuity with an owner-clinician. It also publishes meaningful refund restrictions and contractual language that separates Optima from the professionals providing care. The result is a more specific offering than an unexplained headline price, but not a complete long-term budget. The key decision is whether the written quote and purchase agreement fill the gaps left by the public pages.
At a glance
- Compounded semaglutide
- $249 for an advertised 10-week program, including consultation, medication, supplies and shipping; no membership fee or monthly contract is advertised.Sources: [9]
- Compounded tirzepatide
- $349 for an advertised 10-week program with the same listed inclusions; the supplied pages do not establish later-stage prices.
- Payment and insurance
- Optima does not accept insurance and advertises Affirm and Klarna options. Its terms describe one bundled charge covering Optima and affiliated third-party fees.
- Refund boundary
- The policy offers a full refund for cancellation before medication dispatch, while post-dispatch terms preserve purchase-agreement payment obligations.Sources: [6]
Start with the 10-week price, not an invented monthly bill
Optima’s semaglutide page states a $249 price for 10 weeks; its tirzepatide page states $349 for 10 weeks. Neither quoted offer uses “starting at” language. Both say consultation with a licensed provider, medication, supplies and shipping are covered, alongside claims of no membership fee, no monthly contract and no surprise charges. These are provider representations about the advertised packages, not an independently tested guarantee that every possible service or future stage carries the same terms.
The documented offerings are compounded injectable medications. The weight-loss page identifies semaglutide injections as subcutaneous, but the supplied pricing excerpts do not specify concentration, vial presentation, total dispensed quantity or shipment count. A 10-week program label should therefore remain a duration description, not be converted into an assumed number of vials or a particular supply arrangement. Likewise, it does not by itself show when the full charge is collected or whether an installment arrangement applies.
For budgeting, keep the advertised package intact and ask for its actual checkout terms. Our guide to understanding the first GLP-1 payment explains why the charge authorized today matters more than a monthly equivalent. Here, the practical comparison is between two stated 10-week offers, followed by a separate inquiry into the next stage. There is no need to manufacture a monthly or annual total that Optima has not published.
| Cost component | Documented offer | Clarification to request |
|---|---|---|
| Compounded semaglutide | $249 for 10 weeks | Exact presentation, quantity and amount charged at checkout |
| Compounded tirzepatide | $349 for 10 weeks | Exact presentation, quantity and amount charged at checkout |
| Included services | Consultation, medication, supplies and shipping | Whether any separately ordered services fall outside the package |
| Continuing care | Semaglutide price and weeks shown before the next decision | Written price and duration for the proposed next stage |
| Payment alternatives | Affirm and Klarna advertised | Eligibility, interest, fees and payment schedule |
Included services are clearer than the continuing-care budget
The consultation is explicitly included in both advertised programs, while the homepage separately promotes a free consultation in person or by video. Those descriptions give a prospective patient a route to discuss goals before choosing a treatment path. They do not fully explain whether the free consultation and the package’s clinical consultation are identical appointments. Optima also advertises a personalized meal plan on its general weight-loss page, but that page does not separately price the plan or describe its delivery schedule.
The terms reinforce the bundled-price message: fees associated with Optima and third-party affiliates, including laboratories, providers and pharmacies, are combined into one charge and included in the displayed program price. That is useful billing information, but it does not identify which tests, if any, a particular patient must complete. The supplied pages do not establish mandatory laboratory testing, a fixed follow-up schedule or an itemized price for services outside the advertised program.
For semaglutide, Optima says a provider reviews response at the end of each program and shows the price and number of weeks before the patient decides on the next step. No subsequent tariff is supplied here. The opening price is not explicitly labeled an introductory discount, but it is not documented as a permanent rate either. Use the distinction in our guide to introductory offers and renewal prices: a clear first package can coexist with an incomplete continuing-care budget.
Self-pay, financing and reimbursement are separate questions
Optima says it does not accept insurance. That makes its public offer a self-pay proposition rather than a promise to obtain plan coverage. The homepage also advertises buy-now-pay-later options, including Affirm and Klarna. These are payment alternatives, not evidence that financing is mandatory or cost-free. The consulted material does not establish interest rates, financing fees, approval requirements, available installment schedules or a discount for paying without financing.
The terms say Optima provides superbills or other medically coded invoices and supplies regular invoices on request. They specifically decline responsibility for approval or denial of reimbursement by an HSA or FSA provider. An invoice is useful documentation, but it is not a reimbursement guarantee. Readers should settle their own account administrator’s requirements separately rather than treating the clinic’s willingness to provide paperwork as confirmation that a particular expense will be accepted.
Before authorizing payment, request the exact amount due immediately, any remaining payment schedule and the agreement governing a financed purchase. The public language about one bundled charge explains how service fees are grouped; it does not settle how every payment alternative collects money. Our guide to insurance and self-pay questions helps separate provider billing from possible outside reimbursement. Neither financing nor potential reimbursement should be used to obscure the underlying program price.
Dispatch changes the refund position
Optima’s cancellation policy places considerable importance on medication dispatch. It offers a full refund when an order is canceled before the medications have been dispatched to the patient’s home. The policy describes returning funds to the original payment method after confirming cancellation without shipment. The supplied material does not establish a bank-arrival deadline for that refund. A reader should not assume that asking to cancel instantly stops a pharmacy order or immediately restores available funds.
After dispatch, the policy says the buyer must fulfill the purchase agreement, including its payment schedule, and states that medications already shipped and received are not refundable. Another provision says agreed payments remain due for the specified purchase-agreement duration regardless of whether medications have been received or predicted results achieved. That wording deserves attention alongside the sales pages’ “no monthly contract” claim: absence of a monthly membership does not eliminate obligations under a particular purchase agreement.
The practical checkpoint is dispatch, not arrival. Ask how cancellation must be submitted, how confirmation is issued and how to determine whether the pharmacy has already sent the order. The supplied pages also leave automatic renewal, reminders and authorization of future charges unresolved. Our guide to cancellation and refund boundaries distinguishes ending future service from recovering money already committed. Optima’s public policy offers a meaningful pre-dispatch boundary, but it should not be read as a general satisfaction guarantee.
The purchase begins with clinical evaluation, not a guaranteed prescription
Optima describes itself as a locally owned specialty medical clinic offering both in-clinic and telehealth visits. Its homepage describes access for people 18 or older in Texas, with other states presented as a future expansion. The semaglutide page says the entire program can be completed by telehealth anywhere in Texas; visiting Tyler is optional. That geographic access statement is not a complete clinical eligibility policy, and the supplied material does not establish the program’s full admission criteria.
The terms expressly say payment does not guarantee prescribing or dispensing. They require a medical intake form, an established patient-provider relationship, a consultation and medical need determined through the provider’s professional judgment. Optima says the initial choice between semaglutide and tirzepatide considers history, goals and budget. These are meaningful process details: the advertised package is not simply a retail medication purchase, and the price does not establish that either option will be appropriate for a particular applicant.
The service describes more personal continuity than a rotating-provider model: the team page promises the same licensed provider from the first visit through follow-ups and says patients are always seen by an owner, Dan or Travis. Those are service promises from Optima, not findings from observed appointments. For cost planning, ask who conducts the free consultation, who makes prescribing decisions and whether additional follow-ups beyond the package carry a charge. The public pages do not supply a fixed visit frequency.
Pharmacy delivery and support need their own cost questions
Optima advertises direct-to-door delivery in discreet packaging, with ongoing support and refills available by message. The package prices include shipping, but the supplied pages do not establish preparation, dispatch or arrival timelines, a carrier, shipment frequency or procedures for a lost package. Those omissions matter when planning a purchase: included shipping describes a cost component, not a delivery guarantee. The terms identify Grand Avenue Pharmacy in Pflugerville as an affiliate, with a published telephone number of (512) 377-1999.
That affiliation does not confirm which pharmacy fulfills every preparation or order. Optima says its medications are made in a Texas State Board of Pharmacy-licensed sterile compounding pharmacy and describes a pharmacy partner as LegitScript certified. These are site claims, not independently verified credentials in this review. Its wording elsewhere includes “FDA-licensed 503(a),” which this research does not validate. The useful question before payment is the identity and contact information of the pharmacy responsible for the actual prescription.
For support, the weight-loss page advertises text access to a licensed family nurse practitioner through Spruce during business hours, and the semaglutide page promises help becoming comfortable with injections. Neither statement establishes round-the-clock availability or a response-time guarantee. FDA advises patients not to use injectable GLP-1 medication arriving warm or insufficiently refrigerated and to contact the provider or dispensing pharmacy. Ask in advance who handles delivery concerns, replacement requests and any resulting charges; the supplied policy does not resolve those details.
The lower advertised package is not a branded-drug price
Optima says it exclusively offers compounded medications and does not offer Wegovy, Ozempic, Mounjaro or Zepbound. Its semaglutide page also warns that compounded preparations are not FDA approved and should not be presented as equivalent to approved products. Those disclosures belong beside the prices, not in an afterthought: a shopper comparing Optima with a branded-product service is comparing different documented offerings. The advertised amount cannot be described as the price of one of those excluded brands.
FDA explains that compounded preparations do not undergo its premarket review for safety, effectiveness and quality. It recommends compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone is not proof of clinical inequivalence, nor does it establish that a particular provider is good or bad. FDA approval concerns a specific product; it should not be inferred from a clinic’s credentials, pharmacy relationship or certification claims.
Price also cannot establish likely results. Clinical trials of approved products do not measure outcomes for Optima’s compounded preparations or predict an individual patient’s response. NIDDK describes medication selection as involving benefits, side effects, health conditions, other medicines, family history and cost, with follow-up addressing tolerance and response. A sensible budget conversation therefore asks what care remains available if the initial plan changes—not merely which headline is cheaper. The supplied evidence does not provide provider-specific measured outcomes.
Confirm the people, location and responsible entities before paying
Optima presents Daniel Black as an FNP-C certified through AANPCB and Travis Squyres as an APRN, FNP-C, AANPCB-certified co-owner. These are nurse-practitioner credentials, not physician titles. Travis’s biography publishes Texas license information and an NPI, and the site claims Optima is LegitScript certified. This review has not independently checked those records or certifications. The business also advertises testosterone replacement for men and peptide therapies, so GLP-1 care is one part of its documented service range.
The terms introduce a distinction worth resolving: despite the clinic presentation, they say Optima itself is not acting as a healthcare provider and that the patient-provider relationship may be with individual professionals. They also say Optima is not acting as a pharmacy. That does not establish a legal conclusion, but it leaves a practical question: which entity handles clinical concerns, billing disputes and pharmacy problems? The terms allow requests for a record copy or summary, usually within 30 days, with a possible reasonable cost-based fee.
Contact details also require confirmation. The contact page lists 110 West Erwin Street, Suite B, in its main text but 327 West Houston Street in its footer. Homepage hours differ over weekday closing times and Saturday availability. Call (903) 459-6864 or use the appointment-request form before traveling; the form promises a response “shortly” without a quantified deadline. These discrepancies do not establish the quality of care, but confirming them can prevent an avoidable trip and clarify when business-hours support is actually available.
Questions & answers
Are Optima Tyler’s $249 and $349 prices monthly charges?
No. The advertised prices cover 10-week programs: $249 for compounded semaglutide and $349 for compounded tirzepatide. Consultation, medication, supplies and shipping are listed as included. The duration does not establish the dispensed quantity, shipment count or mandatory payment term. Ask for the actual checkout amount and payment schedule rather than treating either offer as a recurring monthly bill.
What does Optima charge after the first program?
The supplied pages do not publish a complete later-stage price schedule. The semaglutide page says the provider reviews response at the end of each program and shows the next price and number of weeks before the patient decides. That is a disclosure promise, not a rate lock. Request the proposed continuation price, covered services and authorization process before agreeing to another purchase.
Can I use insurance, Affirm, Klarna or reimbursement paperwork?
Optima says it does not accept insurance and advertises Affirm and Klarna payment alternatives. Their interest, fees and approval terms are not established in the consulted material. Optima’s terms also say it provides superbills or medically coded invoices, without guaranteeing HSA or FSA reimbursement. Confirm payment-provider terms and account-administrator requirements separately; neither an installment offer nor an invoice changes the underlying program price.
Can I cancel before the medication arrives and receive a refund?
Arrival is not the policy’s principal cutoff. Optima offers a full refund for cancellation before dispatch. Once medication has been dispatched, the policy preserves purchase-agreement obligations and excludes refunds for medication shipped and received. Another clause retains agreed payments regardless of receipt or predicted results. Obtain cancellation confirmation and shipment status promptly; the supplied material does not promise when refunded money will reach a bank account.
Do Texas patients have to visit the Tyler office?
Optima says no: the program can be completed through telehealth anywhere in Texas, with medication shipped home. The homepage describes access for adults 18 and older, but that does not guarantee clinical eligibility or a prescription. If you prefer an office visit, confirm the address and hours by phone because the supplied pages publish conflicting locations and schedules.
Does Optima’s offer include Wegovy or Zepbound?
No. Optima says it exclusively offers compounded medications and specifically excludes Wegovy, Ozempic, Mounjaro and Zepbound. Its own disclosures state that compounded preparations are not FDA approved and should not be presented as equivalent to approved products. FDA recommends compounding when an individual’s medical needs cannot be met by an approved drug. Discuss that distinction with the treating clinician rather than assuming the advertised package is a branded-product substitute.
Our assessment
Optima Tyler provides a useful degree of immediate price specificity: two named compounded injectable programs, defined 10-week durations and explicit inclusion of consultation, medication, supplies and shipping. Statewide Texas telehealth, advertised owner-clinician continuity and business-hours messaging also give the offering a recognizable care model. Those details make the initial purchase easier to examine than an unexplained monthly headline. The unresolved issue is the cost and responsibility structure beyond that initial offer. Later-stage prices, exact presentations and quantities, follow-up frequency, payment authorization mechanics and delivery-remedy procedures are not fully documented in the supplied pages. The dispatch-based refund boundary and purchase-agreement obligations deserve particular attention before using installment financing. Conflicting office information and the distinction between Optima’s commercial identity and individual clinicians’ responsibilities also warrant direct confirmation. For a prospective patient, the strongest next step is a written quote identifying the immediate charge, medication presentation, dispensing pharmacy, included care, proposed continuation terms and cancellation procedure. The public prices are concrete enough to begin a comparison, but not enough to establish a long-term budget or predict clinical results.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Optima Tyler — weight loss ↗
- Optima Tyler — privacy policy ↗
- Optima Tyler — tirzepatide ↗
- Optima Tyler — about/travis squyres ↗
- Optima Tyler — semaglutide ↗
- Optima Tyler — contact ↗
- Optima Tyler — about ↗
- Optima Tyler — official website ↗